Chromatography in plasma fractionation: benefits and future trends

研究成果: 雜誌貢獻回顧型文獻

79 引文 斯高帕斯(Scopus)

摘要

Industrial-scale chromatographic fractionation and purification methods have been used increasingly in the last few years for plasma fractionation. This has resulted in the development of a new generation of therapeutic plasma derivatives, especially coagulation factors, protease inhibitors and anticoagulants. Implementation and combination of ion-exchange, affinity and size-exclusion chromatography have allowed the development of new therapeutic products with improved purity and safety for treating congenital or acquired plasma protein deficiencies in patients. More recently, the benefit of chromatographic purification of plasma proteins in the removal of plasma-borne viruses has been revealed. Development of packing materials with improved characteristics for industrial applications, including higher capacity and rigidity, should further promote the use of chromatography as an essential plasma fractionation tool and confine more and more the traditional ethanol precipitation methods to the final processing stages used to recover albumin.
原文英語
頁(從 - 到)3-15
頁數13
期刊Journal of Chromatography B: Biomedical Sciences and Applications
664
發行號1
DOIs
出版狀態已發佈 - 二月 3 1995
對外發佈Yes

ASJC Scopus subject areas

  • Chemistry(all)

指紋 深入研究「Chromatography in plasma fractionation: benefits and future trends」主題。共同形成了獨特的指紋。

  • 引用此